NASDAQ
ImmunoGen, Inc. (IMGN) has a current ratio of 2.26x as of Tuesday, May 26, 2026. This represents a 31.40% decrease compared to its 12-month average of 3.29x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.